Showing results (1031-1040 of 1,192) with videos related to

Sort By:
Pageof 120
BMC Pharmacology & Toxicology|April 20, 2023
Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitroMarcin Kunecki, Tomasz Oleksy, Jan Martynów, et al.
BMC Pharmacology & Toxicology|May 12, 2023
β-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathwayOmayma Ar Abo-Zaid, Fatma Sm Moawed, Effet Soliman Ismail, et al.
BMC Pharmacology & Toxicology|November 15, 2012
Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophagesMarianne Jennifer Ratcliffe, Iain Gordon Dougall
BMC Pharmacology & Toxicology|June 3, 2014
Uridine prevents tamoxifen-induced liver lipid droplet accumulationThuc T Le, Yasuyo Urasaki, Giuseppe Pizzorno
BMC Pharmacology & Toxicology|June 27, 2014
Microbiological contamination in counterfeit and unapproved drugsDieter Pullirsch, Julie Bellemare, Andreas Hackl, et al.
BMC Pharmacology & Toxicology|July 31, 2020
Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic modelMemoona Rashid, Muhammad Sarfraz, Mosab Arafat, et al.
BMC Pharmacology & Toxicology|July 31, 2020
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjectsYoshiaki Kirigaya, Masanari Shiramoto, Tomoko Ishizuka, et al.
BMC Pharmacology & Toxicology|August 9, 2020
Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver diseaseHe Lin, Houlei Teng, Wei Wu, et al.
BMC Pharmacology & Toxicology|April 8, 2021
Coenzyme Q10 protected against arsenite and enhanced the capacity of 2,3-dimercaptosuccinic acid to ameliorate arsenite-induced toxicity in miceVictoria K Mwaeni, James N Nyariki, Ngalla Jillani, et al.
BMC Pharmacology & Toxicology|April 17, 2021
Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health centerJoelle Ayoub, Jessina C McGregor, Rebecca M Castner, et al.
Pageof 120